FDA-cleared profile

syngo.CT Coronary Cockpit

Siemens Medical Solutions USA, Inc. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.

Clinical role
Automated and semi-automated coronary-vessel, lumen, wall and plaque analysis with reporting support.
Images and patients
CT/CTA · Heart/Cardiovascular
Key limitation
Keep in mind: The product does not replace clinical judgment. Interpolated CT data may cause tissue near or below scanning resolution to appear healthy; outputs require trained-user review.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Heart/Cardiovascular Input: Cardiac CT angiography volume datasets in the syngo.via environment.
  • Who uses it?Intended users: Trained users with appropriate skill, experience and judgment; a physician is responsible for confirming lesion presence or absence and clinical use of results.
  • What does the software produce?Output: Processed coronary-vessel visualization, quantification and reporting information for physician confirmation and documentation.
  • What is its most important limitation?Key limitation: The product does not replace clinical judgment. Interpolated CT data may cause tissue near or below scanning resolution to appear healthy; outputs require trained-user review.

Clinical takeaway. Clinical role: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.

Evidence takeaway. Evidence from the reviewed source record: Technical FDA testing used multi-country cardiac-CTA datasets; reported vessel-tracing results apply to the specified anatomical and image-quality criteria, not to clinical diagnosis or treatment benefit.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.
  • Exact FDA submission
  • Checked 2026-09-06
Workflow role
Automated and semi-automated coronary-vessel, lumen, wall and plaque analysis with reporting support.
  • Exact FDA submission
  • Checked 2026-09-06
Required input
Cardiac CT angiography volume datasets in the syngo.via environment.
  • Exact FDA submission
  • Checked 2026-09-06
Output and clinician action
Processed coronary-vessel visualization, quantification and reporting information for physician confirmation and documentation.
  • Exact FDA submission
  • Checked 2026-09-06
Care setting
Cardiac CT angiography workflow; no care-site restriction was established in the reviewed FDA summary.
  • Exact FDA submission
  • Checked 2026-09-06
Intended users
Trained users with appropriate skill, experience and judgment; a physician is responsible for confirming lesion presence or absence and clinical use of results.
  • Exact FDA submission
  • Checked 2026-09-06
Limitations
The product does not replace clinical judgment. Interpolated CT data may cause tissue near or below scanning resolution to appear healthy; outputs require trained-user review.
  • Exact FDA submission
  • Checked 2026-09-06
Evidence summary
Technical FDA testing used multi-country cardiac-CTA datasets; reported vessel-tracing results apply to the specified anatomical and image-quality criteria, not to clinical diagnosis or treatment benefit.
  • Exact FDA submission
  • Checked 2026-09-06

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Technical FDA testing used multi-country cardiac-CTA datasets; reported vessel-tracing results apply to the specified anatomical and image-quality criteria, not to clinical diagnosis or treatment benefit.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Reported sensitivity
95.8
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06

Vessel-tracing sensitivity for vessels at least 1.5 mm in the FDA technical-performance dataset; not diagnostic sensitivity for coronary disease.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

No disease-detection specificity was established by the reviewed technical-performance summary.

Vessel-tracing sensitivity

95.8 percent

  • EndpointSensitivity of vessel tracing for coronary vessels at least 1.5 mm
  • Population425 cardiac-CTA datasets from five US states and three European countries; CT slice thickness 0.2-1.0 mm and 70-140 kVp
  • Tested versionsyngo.CT Coronary Cockpit (SOMARIS/8 VC10)

Coronary-vessel tracing failure rate

0 percent

  • EndpointFailure rate for the technical vessel-tracing evaluation
  • PopulationSame 425 cardiac-CTA technical-performance datasets
  • Tested versionsyngo.CT Coronary Cockpit (SOMARIS/8 VC10)

K253786 coronary CTA technical performance evaluation

  • DesignManufacturer technical-performance evaluation against expert/reference annotations
  • Population425 cardiac-CTA datasets for vessel tracing; random 150-dataset subset for lumen and wall evaluation
  • Scopeexact submission
  • Tested versionsyngo.CT Coronary Cockpit (SOMARIS/8 VC10)
  • Samplen=425
  • IndependenceSponsor or vendor study

K253786

The summary describes geographically diverse datasets and quantitative segmentation/tracing endpoints. It is not a prospective clinical-outcome study.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Cardiac CT angiography volume datasets in the syngo.via environment.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-06 · FDA 510(k) K253786: syngo.CT Coronary Cockpit

  2. Routing

    Source context, not route validation: Operates as an extension for multi-modality reading on syngo.via.

    Scope: Exact FDA submission. Current View&GO documentation is family context only, not proof of exact VC10 deployment compatibility.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-06 · FDA 510(k) K253786: syngo.CT Coronary Cockpit

  3. AI processing

    Source context, not route validation: Extension for the syngo.via software platform, not a standalone device.

    Scope: Exact FDA submission. The reviewed summary does not establish a site-specific hosting architecture.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-06 · FDA 510(k) K253786: syngo.CT Coronary Cockpit

  4. Returned objects

    Source context, not route validation: Processed coronary-vessel visualization, quantification and reporting information for physician confirmation and documentation.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-06 · FDA 510(k) K253786: syngo.CT Coronary Cockpit

  5. Viewer/worklist/report

    Unresolved route: Processed coronary-vessel visualization, quantification and reporting information for physician confirmation and documentation.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-06 · FDA 510(k) K253786: syngo.CT Coronary Cockpit

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Extension for the syngo.via software platform, not a standalone device.
  • Exact FDA submission
  • Checked 2026-09-06

The reviewed summary does not establish a site-specific hosting architecture.

Integration
Operates as an extension for multi-modality reading on syngo.via.
  • Exact FDA submission
  • Checked 2026-09-06

Current View&GO documentation is family context only, not proof of exact VC10 deployment compatibility.

Security
Siemens Healthineers' corporate cybersecurity page states a Secure Development Lifecycle addressing pre-market and post-market phases for products under development and a range of existing offerings; a Cybersecurity Management Service maintaining a product security inventory (over 1,000 product versions and over 21,000 monitored software components) with security whitepapers, SBOMs and vulnerability assessments available to customers via teamplay Fleet; incident and vulnerability management channels; and that Siemens Healthineers AG maintains an independent certification of its global Cybersecurity Management System to ISO/IEC 27001:2022 extended by ISO/IEC 27701:2019, with the certificate referenced to the SGS directory. Vendor statement; no certificate or report was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: Siemens Healthineers' own corporate-info page names Siemens Medical Solutions USA, Inc. (Malvern, PA), and its 2024 governance press release states Siemens Healthcare GmbH's business was transferred to Siemens Healthineers AG. Corporate program statement; exact-release scope is not established.

Monitoring
Siemens Healthineers' cybersecurity page states that its Cybersecurity Management Service maintains a product security inventory of over 1,000 product versions and over 21,000 monitored software components, with security whitepapers, SBOMs and vulnerability assessments delivered via teamplay Fleet, and that it operates incident and vulnerability management.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The page names Siemens Healthineers generally and does not scope these commitments to any specific product release; exact-release scope is not established.

Current-family workstation requirements

The syngo.via View&GO VA55 operator manual lists Windows 11 64-bit, an Intel AVX2-capable CPU and at least 16 GB RAM when using syngo.CT Coronary Cockpit.

product family · checked 2026-09-06

VA55 documentation is later family context and does not establish the exact K253786 VC10 configuration.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K253786
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-06-25
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-06Last searched
22Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

Stored PubMed and ClinicalTrials candidate metadata snapshots were screened; both arrays were empty. No candidate evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision summary, vendor documentation, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-06 - Exact FDA submission

    No exact submission price or public procurement record reviewed.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "syngo.CT Coronary Cockpit reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. The Siemens Healthineers announcement of this product was read and states no coding or payment; a CMS billing article for AI-enabled coronary CT analysis (A59769) is kept as an unbound lead. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-06 - Exact FDA submission

    The summary requires trained users but does not establish a current vendor training program or site competency process.

8 sources - 3 history items

Source ledger

  1. FDA 510(k) K253786: syngo.CT Coronary Cockpit

    U.S. Food and Drug Administration - Accessed 2026-09-06

    Scope: identity, clinicalUse, modality, anatomy, implementationCapabilities, evidenceStudies, reportedSensitivity

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. syngo.CT Coronary Cockpit model card (K253786)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, reportedSensitivity, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. syngo.via View&GO VA55 Operator Manual

    Siemens Healthineers - Accessed 2026-09-06

    Scope: productFamily, implementationCapabilities

  8. Siemens Healthineers: Cybersecurity

    Siemens Healthineers - Accessed 2026-10-26

    Scope: security

Research history

  1. K253786 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260169

AV Cardiac CT

Philips Medical Systems Nederland B.V.

Authorized purpose: AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2026-03-05
FDA-cleared K252217

CT VScore+

Canon Medical Informatics, Inc.

Authorized purpose: CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-11-28
FDA-cleared K251027

cvi42 Coronary Plaque Software Application

Circle Cardiovascular Imaging, Inc.

Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-10-27

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history